1296 related articles for article (PubMed ID: 11793040)
41. Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection.
Sandborn WJ; Hay JE; Porayko MK; Gores GJ; Steers JL; Krom RA; Wiesner RH
Hepatology; 1994 Apr; 19(4):925-32. PubMed ID: 8138267
[TBL] [Abstract][Full Text] [Related]
42. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus.
Fairbanks KD; Eustace JA; Fine D; Thuluvath PJ
Liver Transpl; 2003 Oct; 9(10):1079-85. PubMed ID: 14526403
[TBL] [Abstract][Full Text] [Related]
43. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients.
Jacob DA; Neumann UP; Bahra M; Klupp J; Puhl G; Neuhaus R; Langrehr JM
Clin Transplant; 2006; 20(2):211-20. PubMed ID: 16640529
[TBL] [Abstract][Full Text] [Related]
44. Non-lymphoid cancer after liver transplantation.
Frezza EE; Fung JJ; van Thiel DH
Hepatogastroenterology; 1997; 44(16):1172-81. PubMed ID: 9261620
[TBL] [Abstract][Full Text] [Related]
45. Rapid steroid taper and neoral monotherapy in liver transplantation in Chile: a step in the right direction?
Innocenti F; Hepp J; Humeres R; Sanhueza E; Zapata R; Rios H; Suárez L; Sandoval R; Rius M; Zamboni M
Transplant Proc; 2004; 36(6):1675-6. PubMed ID: 15350449
[TBL] [Abstract][Full Text] [Related]
46. Single-center experience with cyclosporine therapy for kidney transplantation: analysis of a twenty-year period in 1200 patients.
Snanoudj R; Kriaa F; Arzouk N; Beaudreuil S; Hiesse C; Durrbach A; Charpentier B
Transplant Proc; 2004 Mar; 36(2 Suppl):83S-88S. PubMed ID: 15041313
[TBL] [Abstract][Full Text] [Related]
47. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
Schulz T; Kapischke M; Busing M
Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
[TBL] [Abstract][Full Text] [Related]
48. Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis.
Samonakis DN; Mela M; Quaglia A; Triantos CK; Thalheimer U; Leandro G; Pesci A; Raimondo ML; Dhillon AP; Rolles K; Davidson BR; Patch DW; Burroughs AK
Transpl Infect Dis; 2006 Mar; 8(1):3-12. PubMed ID: 16623815
[TBL] [Abstract][Full Text] [Related]
49. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.
Tjon AS; Sint Nicolaas J; Kwekkeboom J; de Man RA; Kazemier G; Tilanus HW; Hansen BE; van der Laan LJ; Tha-In T; Metselaar HJ
Liver Transpl; 2010 Jul; 16(7):837-46. PubMed ID: 20583092
[TBL] [Abstract][Full Text] [Related]
50. Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation.
Barone GW; Ketel BL; Abul-Ezz SR; Lightfoot ML
JOP; 2002 Mar; 3(2):49-53. PubMed ID: 11884766
[TBL] [Abstract][Full Text] [Related]
51. Five-year experience with triple-drug immunosuppressive therapy in cardiac transplantation.
Olivari MT; Kubo SH; Braunlin EA; Bolman RM; Ring WS
Circulation; 1990 Nov; 82(5 Suppl):IV276-80. PubMed ID: 2225416
[TBL] [Abstract][Full Text] [Related]
52. Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomized clinical study.
Boillot O; Mayer DA; Boudjema K; Salizzoni M; Gridelli B; Filipponi F; Trunecka P; Krawczyk M; Clavien PA; Ducerf C; Margarit C; Margreiter R; Pallardo JM; Hoeckerstedt K; Pageaux GP
Liver Transpl; 2005 Jan; 11(1):61-7. PubMed ID: 15690537
[TBL] [Abstract][Full Text] [Related]
53. Prednisone withdrawal in pediatric kidney transplant recipients on tacrolimus-based immunosuppression: four-year data.
Hamiwka LA; Burns A; Bell L
Pediatr Transplant; 2006 May; 10(3):337-44. PubMed ID: 16677358
[TBL] [Abstract][Full Text] [Related]
54. Everolimus versus azathioprine in a cyclosporine and ketoconazole-based immunosuppressive therapy in kidney transplant: 3-year follow-up of an open-label, prospective, cohort, comparative clinical trial.
Gonzalez F; Espinoza M; Herrera P; Rocca X; Reynolds E; Lorca E; Roessler E; Hidalgo J; Espinoza O
Transplant Proc; 2010; 42(1):270-2. PubMed ID: 20172327
[TBL] [Abstract][Full Text] [Related]
55. Five-year follow-up of a randomized double-drug versus triple-drug therapy immunosuppressive trial after heart transplantation.
Keogh A; Macdonald P; Mundy J; Chang V; Harvison A; Spratt P
J Heart Lung Transplant; 1992; 11(3 Pt 1):550-5; discussion 556. PubMed ID: 1610863
[TBL] [Abstract][Full Text] [Related]
56. Steroid withdrawal in the pediatric heart transplant recipient initially treated with triple immunosuppression.
Canter CE; Moorhead S; Saffitz JE; Huddleston CB; Spray TL
J Heart Lung Transplant; 1994; 13(1 Pt 1):74-9; discussion 79-80. PubMed ID: 8167131
[TBL] [Abstract][Full Text] [Related]
57. Monotherapy with cyclosporine for chronic immunosuppression in pediatric liver transplant recipients.
Dunn SP; Falkenstein K; Lawrence JP; Meyers R; Vinocur CD; Billmire DF; Weintraub WH
Transplantation; 1994 Feb; 57(4):544-7. PubMed ID: 8116039
[TBL] [Abstract][Full Text] [Related]
58. Successful withdrawal of corticosteroids in heart transplantation.
Miller LW; Wolford T; McBride LR; Peigh P; Pennington DG
J Heart Lung Transplant; 1992; 11(2 Pt 2):431-4. PubMed ID: 1571342
[TBL] [Abstract][Full Text] [Related]
59. Influence of treatment with cyclosporine, azathioprine and steroids on chronic allograft failure. The Collaborative Transplant Study.
Opelz G
Kidney Int Suppl; 1995 Dec; 52():S89-92. PubMed ID: 8587292
[TBL] [Abstract][Full Text] [Related]
60. Single-center experience with tacrolimus versus cyclosporine-Neoral in renal transplant recipients.
Boots JM; van Duijnhoven EM; Christiaans MH; Nieman FH; van Suylen RJ; van Hooff JP
Transpl Int; 2001 Dec; 14(6):370-83. PubMed ID: 11793034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
